An Observational Study of Treatment, Outcomes, and Prognosis in Patients With Follicular Non-Hodgkin's Lymphoma

This is a prospective, observational, longitudinal, multicenter study of patients with newly diagnosed follicular Non Hodgkin's Lymphoma (NHL) designed to delineate differences in clinical outcome by comparing the effectiveness and safety of common treatment regimens.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Lymphoma, Non Hodgkin Hemic and Lymphatic Diseases Immune System Diseases Immunoproliferative Disorders Lymphatic Diseases Lymphoma Lymphoma, Follicular Lymphoma, Non-Hodgkin Lymphoproliferative Disorders Neoplasms Neoplasms by Histologic Type

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Signed Informed Consent Form (unless the Institutional Review Board [IRB] has granted a waiver of consent)
Signed Authorization for the Use and Disclosure of Health Information document
Age ≥18 years
Histologic documentation of follicular NHL, according to Revised European-American Lymphoma (REAL) classification system, as assessed by the local pathologist and treating physician
Initial diagnosis of follicular B-cell NHL within 6 months prior to enrollment
Availability of cancer-specific historical data points in the patient's medical records

Exclusion criteria

Other indolent or histologic NHL subtypes
Diagnosis of lymphoma > 6 months prior to enrollment

Sponsors and collaborators

Lead sponsor

Genentech, Inc.

Industry

Registry information

Official study title

The National Lymphocare Study: An Observational Study of Treatment, Outcomes, and Prognosis in Patients With Follicular Non-Hodgkin's Lymphoma

Important dates

Study start: 2004
Primary completion: 2014
Study completion: 2014
First posted: Nov 25, 2004
Registry last updated: Mar 23, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed